Mesothelioma Causes & Risk Factors - Revision history

MesotheliomaSupport: Add links to related pages: Asbestos in Consumer Products, Vermiculite and Libby, Montana, WHO/IARC Talc Classification

2026-04-06T01:11:19Z

Add links to related pages: Asbestos in Consumer Products, Vermiculite and Libby, Montana, WHO/IARC Talc Classification

← Older revision		Revision as of 01:11, 6 April 2026
Line 396:		Line 396:
	* [[Veterans and Asbestos Exposure\|Veterans and Asbestos Exposure]]		* [[Veterans and Asbestos Exposure\|Veterans and Asbestos Exposure]]
	* [[Statute of Limitations\|Statute of Limitations for Mesothelioma Claims]]		* [[Statute of Limitations\|Statute of Limitations for Mesothelioma Claims]]


			== See Also ==
			* [[Asbestos in Consumer Products\|Asbestos in Consumer Products]]
			* [[Vermiculite Libby Montana\|Vermiculite and Libby, Montana]]
			* [[WHO IARC Talc Probably Carcinogenic Group 2A\|WHO/IARC Talc Classification]]

	== References ==		== References ==

MesotheliomaSupport: Internal linking: added 4 wiki links

2026-02-20T20:58:45Z

Internal linking: added 4 wiki links

← Older revision		Revision as of 20:58, 20 February 2026
Line 9:		Line 9:
	{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"		{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"
	\|-		\|-
	! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| Mesothelioma Causes & Risk Factors		! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| [[Mesothelioma]] Causes & Risk Factors
	\|-		\|-
	\| colspan="2" style="border:1px solid #1a5276; padding:10px; text-align:center; font-style:italic;" \| Scientific evidence on asbestos attribution and latency		\| colspan="2" style="border:1px solid #1a5276; padding:10px; text-align:center; font-style:italic;" \| Scientific evidence on asbestos attribution and latency
Line 38:		Line 38:
	== Executive Summary ==		== Executive Summary ==

	Asbestos exposure is the dominant and well-established cause of malignant mesothelioma, accounting for 91.7% of global mesothelioma deaths according to the 2019 Global Burden of Disease study.<ref name="mlcasbestos">[https://www.mesotheliomalawyercenter.org/asbestos/ Asbestos \| Mesothelioma Lawyer Center]</ref><ref name="pmcgbd" /> The median latency period from first exposure to clinical diagnosis spans 32 years, with documented cases ranging from 7 to 70 years. Different asbestos fiber types demonstrate dramatically different potencies: the landmark Hodgson and Darnton (2000) meta-analysis established a risk ratio of 1:100:500 for chrysotile, amosite, and crocidolite respectively, with crocidolite being five hundred times more carcinogenic than chrysotile on a fiber-for-fiber basis.<ref name="dandellexposure">[https://dandell.com/asbestos-exposure/ Asbestos Exposure \| Danziger & De Llano]</ref><ref name="pmchodgson" /> Approximately 80% of mesothelioma cases in men occur from occupational asbestos exposure. However, approximately 20% of mesothelioma cases occur in patients with no identifiable asbestos exposure, highlighting the role of non-asbestos causes—including erionite, radiation, genetic predisposition (BAP1 mutations), carbon nanotubes, and spontaneous mesothelial transformation—in disease pathogenesis.<ref name="mesonetasbestos">[https://mesothelioma.net/asbestos-dangers/ Asbestos Dangers & Health Risks \| Mesothelioma.net]</ref> This comprehensive guide integrates current molecular, epidemiological, and occupational health evidence to establish causation in mesothelioma cases.		[[Asbestos Exposure\|Asbestos exposure]] is the dominant and well-established cause of malignant mesothelioma, accounting for 91.7% of global mesothelioma deaths according to the 2019 Global Burden of Disease study.<ref name="mlcasbestos">[https://www.mesotheliomalawyercenter.org/asbestos/ Asbestos \| Mesothelioma Lawyer Center]</ref><ref name="pmcgbd" /> The median latency period from first exposure to clinical diagnosis spans 32 years, with documented cases ranging from 7 to 70 years. Different asbestos fiber types demonstrate dramatically different potencies: the landmark Hodgson and Darnton (2000) meta-analysis established a risk ratio of 1:100:500 for chrysotile, amosite, and crocidolite respectively, with crocidolite being five hundred times more carcinogenic than chrysotile on a fiber-for-fiber basis.<ref name="dandellexposure">[https://dandell.com/asbestos-exposure/ Asbestos Exposure \| Danziger & De Llano]</ref><ref name="pmchodgson" /> Approximately 80% of mesothelioma cases in men occur from occupational asbestos exposure. However, approximately 20% of mesothelioma cases occur in patients with no identifiable asbestos exposure, highlighting the role of non-asbestos causes—including erionite, radiation, genetic predisposition (BAP1 mutations), carbon nanotubes, and spontaneous mesothelial transformation—in disease pathogenesis.<ref name="mesonetasbestos">[https://mesothelioma.net/asbestos-dangers/ Asbestos Dangers & Health Risks \| Mesothelioma.net]</ref> This comprehensive guide integrates current molecular, epidemiological, and occupational health evidence to establish causation in mesothelioma cases.

	== Key Facts ==		== Key Facts ==
Line 181:		Line 181:
	* '''Product Identification:''' Because decades pass between exposure and diagnosis, reconstructing which manufacturers' products caused disease can be difficult without thorough exposure history documentation.		* '''Product Identification:''' Because decades pass between exposure and diagnosis, reconstructing which manufacturers' products caused disease can be difficult without thorough exposure history documentation.
	* '''Temporal Causation:''' The long latency period, combined with multiple occupational and environmental exposures, sometimes creates disputes about which exposure(s) caused disease.		* '''Temporal Causation:''' The long latency period, combined with multiple occupational and environmental exposures, sometimes creates disputes about which exposure(s) caused disease.
	* '''Trust Fund Eligibility:''' Bankruptcy trust funds for asbestos manufacturers require documented exposure to the defendant's products, regardless of when diagnosis occurred.		* '''Trust Fund Eligibility:''' Bankruptcy [[Trust Funds\|trust funds]] for [[Asbestos Manufacturers\|asbestos manufacturers]] require documented exposure to the defendant's products, regardless of when diagnosis occurred.

	== Which Occupations Carry the Highest Risk? ==		== Which Occupations Carry the Highest Risk? ==

MesotheliomaSupport: Fix broken GBD study PMID 38760850 (glioma article)→36857650 (Han et al. mesothelioma GBD study, Ann Am Thorac Soc 2023)

2026-02-06T22:53:27Z

Fix broken GBD study PMID 38760850 (glioma article)→36857650 (Han et al. mesothelioma GBD study, Ann Am Thorac Soc 2023)

← Older revision		Revision as of 22:53, 6 February 2026
Line 416:		Line 416:
	<ref name="dandellnavy">[https://dandell.com/asbestos-exposure/asbestos-exposure-navy-shipyards/ Asbestos Exposure in Navy Shipyards \| Danziger & De Llano]</ref>		<ref name="dandellnavy">[https://dandell.com/asbestos-exposure/asbestos-exposure-navy-shipyards/ Asbestos Exposure in Navy Shipyards \| Danziger & De Llano]</ref>
	<ref name="mesoattcancer">[https://mesotheliomaattorney.com/mesothelioma/cancer/ Mesothelioma Cancer \| Mesothelioma Attorney]</ref>		<ref name="mesoattcancer">[https://mesotheliomaattorney.com/mesothelioma/cancer/ Mesothelioma Cancer \| Mesothelioma Attorney]</ref>
	<ref name="pmcgbd">[https://pubmed.ncbi.nlm.nih.gov/~~38760850~~/ ~~Li M~~, ~~Tian Y~~, et al. Global, regional, and national burden of mesothelioma, 1990-2019: ~~Results from~~ the Global Burden of Disease Study 2019. ''~~Environ Health Perspect~~.'' ~~2024~~;~~132~~(5):~~057001~~.]</ref>		<ref name="pmcgbd">[https://pubmed.ncbi.nlm.nih.gov/36857650/ Han J, Park S, Yon DK, et al. Global, regional, and national burden of mesothelioma 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. ''Ann Am Thorac Soc.'' 2023;20(7):1006-1017.]</ref>
	<ref name="pmchodgson">[https://pubmed.ncbi.nlm.nih.gov/11108782/ Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. ''Ann Occup Hyg.'' 2000;44(8):565-601.]</ref>		<ref name="pmchodgson">[https://pubmed.ncbi.nlm.nih.gov/11108782/ Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. ''Ann Occup Hyg.'' 2000;44(8):565-601.]</ref>
	<ref name="oshaasbestos">[https://www.osha.gov/asbestos Asbestos, Occupational Safety and Health Administration, U.S. Department of Labor]</ref>		<ref name="oshaasbestos">[https://www.osha.gov/asbestos Asbestos, Occupational Safety and Health Administration, U.S. Department of Labor]</ref>

MesotheliomaSupport: Comprehensive causes & risk factors page: asbestos fiber potency hierarchy, latency periods, occupational risk data, non-asbestos causes (erionite, BAP1, SV40, carbon nanotubes), OSHA regulatory history

2026-02-06T21:24:14Z

Comprehensive causes & risk factors page: asbestos fiber potency hierarchy, latency periods, occupational risk data, non-asbestos causes (erionite, BAP1, SV40, carbon nanotubes), OSHA regulatory history

Show changes